Free tool

Diagnostics stocks

We cover 11 companies grouped under the Diagnostics theme. The median market value in the group is $386.24M. Across the group, the median move over the past trading day is +0.43%. Price change over the past year runs from −30.6% to +70.2% across the middle 80 percent of the group, with a median of −13.4%. Across the group, 1 company currently carries a tier A volume signal.

Other lists in this group

Table

11 of 150 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
CAICaris Life Sciences, Inc.$7.38BMid cap−27.21%
CDNACareDx, Inc.$2.63BMid cap+298.43%
CSTLCastle Biosciences, Inc.$1.02BSmall cap+70.15%
IDX.AXIntegral Diagnostics Limited$638.89MSmall cap−17.78%
CEVI.STCellaVision AB (publ)$413.78MSmall cap−3.32%
ACL.AXAustralian Clinical Labs Limited$386.24MSmall cap+12.06%
YDESYD Bio Ltd$331.49MSmall cap−64.97%
0RAR.LStratec SE$275.63MSmall cap−13.37%
XGNExagen Inc.$184.11MSmall cap−22.84%
4671.TFALCO HOLDINGS Co., Ltd.$179.10MSmall cap+21.25%
BVXP.LBioventix PLC$124.78MSmall cap−30.64%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse